Recent Finacing
Recent Raise
Gen9 operates a high-throughput automated gene-synthesis platform (BioFab) that produces and ships double-stranded DNA constructs 500–1,024 bp and synthesizes large oligonucleotide libraries.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor